ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Key Considerations When Choosing A Device For Dry Powder Nasal Delivery

  Building on previous discussions, here we discuss the benefits of nasal delivery and the challenges of developing dry powder formulations by focusing on key devices that can be used for delivering dry powder nasal dosage forms.

• New Polymer Overcomes Limits In Sustained Drug Delivery In Ophthalmology

  Challenges specific to eye physiology complicate the development of new therapies and necessitate innovative drug delivery methods. Biodegradable polymers show promise in addressing these challenges.

• Pediatric Dosage Form Development: Program Design And Formulation Development

  Explore key considerations to successfully bridge from initial concept of pediatric program design and formulation development strategies into later stages of development and through to commercialization.

• Vial Adapter Transfer Device Compatibility With Cell Therapies

  Needles and syringes are commonly used to retrieve cell therapies from vials, posing the risk of needle stick injury. Explore the suitability of needle-free polycarbonate transfer devices.

• Navigating PFAS "Forever Chemicals" In Medical Devices - What's On The Horizon

  Gain an understanding of PFAS, their properties, environmental impact, health risks, and regulatory challenges, focusing on the specific implications for the medical device industry.

• Improved Biomanufacturing Processes And Drug Product Stability

  Improve upstream media for bioavailability and foam stability, downstream buffers for purification, and the formulation and final fill drug product stability with this highly interdisciplinary process.

• Understanding Of Amorphous Solid Dispersions & Their Downstream Development

  Understanding the properties of ASDs and their relationship to the downstream product scale up, stability, and in-vivo performance is critical to successfully utilize them for drug delivery of insoluble drugs.

• Liposome Vs. Lipid Nanoparticle: What's The Difference?

  Here, we discuss the differences between nanoparticles and liposomes along with their applications in medicine.

• Implantable Drug Delivery: Are We There Yet?

  Implantable drug delivery offers precise, localized treatment, yet biological barriers and market complexities remain. Explore the factors determining if these systems are ready for broad adoption.

• Contract Design And Development Vs. In-House: How To Find The Best Fit

  Explore the rationale behind opting for a contract development organization (CDO) to fulfill organizational requirements and underscore vital considerations for evaluating CDOs to ensure alignment with your project objectives.